[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes one medical product company Kelley-Ross Compounding.[ Price : $8.95]
Federal Register notice: FDA determines that chikungunya virus disease, Lassa fever, rabies, and cryptococcal meningitis satisfy i...[ Price : $8.95]
Federal Register notice: FDA determines that Pneumocystis pneumonia does not meet statutory criteria for designation as a tropical...[ Price : $8.95]
FDA proposes to ban three bulk drug substances bumetanide, nicardipine hydrochloride, and vasopressin from its list of bulk drug...[ Price : $8.95]
Stakeholders ask for clarifications to an FDA draft guidance on assessing drugs pressor effects.[ Price : $8.95]
Former FDA commissioner Robert Califf and Verily Life Sciences researchers suggest it is possible to use digital measurement tools...[ Price : $8.95]
FDA approves a Shire BLA for Takhzyro (lanadelumab-flyo) injection for preventing hereditary angioedema attacks in patients 12 yea...[ Price : $8.95]
FDA approves Janssen Biotech and Pharmacyclics Imbruvica (ibrutinib) in combination with Genentechs rituximab for treating Waldens...